Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G
Laboratoire Universitaire d'Immunologie (UPRES EA 1257 - IFR 97), Université de, Rennes 1 and Etablissement Français du Sang Bretagne Rennes, France.
Tissue Antigens. 2003 Feb;61(2):166-71. doi: 10.1046/j.0001-2815.2002.00008.x.
Among candidate genes involved in multiple sclerosis (MS) genetic susceptibility, MHC genes and particularly HLA-DRB11501-DQB10602 haplotype play a major role. Based on the strong linkage disequilibrium observed in Caucasians between DRB11501 and DQB10602 alleles, it is still impossible to draw a firm conclusion about the DRB1 or DQB1 locus involvement. In order to address this issue a strategy associating a genetic and a functional approach was conducted in a population of-non-Caucasian MS patients. We observed that in Martinicans (55 MS and 100 controls), the DRB115 and DRB107 alleles were positively associated with the disease. However in Martinicans the most common DRB115 subtype was 1503 and not 1501. Moreover, in Martinicans, the frequency of DQB10602, found in association with other DRB1 alleles than DRB115 (42% of DQB10602 haplotypes), was not increased in DRB115-negative MS patients, suggesting a neutral role of DQB10602 in MS genetics. In a second step, we demonstrated the capability of the DRB11503 allele associated with MS in Martinicans to present the immunodominant autoantigen MBP 85-99 peptide to a DRB11501 restricted MBP specific T cell line. Interestingly, structural features of DRB11501 or DRB11503 molecules are in good fit with the hypothesis that 1501 and 1503 molecules may act similarly in MS development by presenting the same immunodominant MBP peptide. On the whole, our results show a prominent role of the DRB1 locus (DRB11501 and/or DRB11503 alleles) in the immunodominant MBP 85-99 peptide presentation to genetically different MS patients and suggest a neutral role of the DQB1 encoded molecule in MS susceptibility.
在参与多发性硬化症(MS)遗传易感性的候选基因中,MHC基因尤其是HLA - DRB11501 - DQB10602单倍型起着主要作用。基于在高加索人群中观察到的DRB11501和DQB10602等位基因之间强烈的连锁不平衡,关于DRB1或DQB1基因座的参与仍无法得出确凿结论。为了解决这个问题,在非高加索MS患者群体中开展了一项将遗传学方法与功能学方法相结合的策略。我们观察到,在马提尼克岛人(55例MS患者和100例对照)中,DRB115和DRB107等位基因与该疾病呈正相关。然而,在马提尼克岛人中,最常见的DRB115亚型是1503而非1501。此外,在马提尼克岛人中,与DRB115以外的其他DRB1等位基因相关联的DQB10602的频率(占DQB10602单倍型的42%),在DRB115阴性的MS患者中并未增加,这表明DQB10602在MS遗传学中起中性作用。在第二步中,我们证明了在马提尼克岛人与MS相关的DRB11503等位基因能够将免疫显性自身抗原MBP 85 - 99肽呈递给受DRB11501限制的MBP特异性T细胞系。有趣的是,DRB11501或DRB11503分子的结构特征与以下假设高度契合:1501和1503分子可能通过呈递相同的免疫显性MBP肽在MS发展过程中发挥相似作用。总体而言,我们的结果表明DRB1基因座(DRB11501和/或DRB11503等位基因)在向遗传背景不同的MS患者呈递免疫显性MBP 85 - 99肽方面起突出作用,并提示DQB1编码分子在MS易感性中起中性作用。